Amgen Keeps Patent Protection for Enbrel With Supreme Court Decision
The U.S. Supreme Court declined to hear Novartis AG's appeal of a lower court's decision on Monday, allowing Amgen Inc. to keep its patent protection for the rheumatoid arthritis d…
